Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SNRPGP14 is a human pseudogene corresponding to the small nuclear ribonucleoprotein polypeptide G gene. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically do not produce functional proteins and are generally considered "genetic fossils." SNRPGP14 is annotated as a non-coding genomic sequence in major databases and is not reported to have any established molecular function, role in human disease, or relevance as a therapeutic target[3]. Errors and limitations: - SNRPGP14 is not an active gene product (e.g., not a receptor, enzyme, or transport protein), and thus not a drug target. - There is no evidence for expression, functional RNA products, or disease association for SNRPGP14 specifically[3]. - The abbreviation is standardized as SNRPGP14, matching its genomic annotation. - If the intention was to refer to a functional small nuclear ribonucleoprotein (such as SNRPG), this should be clarified—the current entry only describes the pseudogene. Summary: SNRPGP14 is a non-coding pseudogene, not an active molecular target, with no known therapeutic, functional, or biomarker relevance[3]. There is no evidence of any drugs or biologically relevant molecules interacting with it. The target as described is not suitable for therapeutic targeting and the entry is likely incorrect if a protein-coding or functional RNA gene was intended.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide G pseudogene 14 (SNRPGP14).